Original Research Focus on Geriatric Psychiatry August 6, 2025

Delineating the Effects of Alcohol Use on Cognition in Individuals With Neurocognitive Disorders

; ; ; ; ; ; ; ; ; ;

J Clin Psychiatry 2025;86(3): 24m15738

Abstract

Objective: Excessive alcohol use is a recognized modifiable risk factor for the development of dementia; however, the neuropsychological profile of cognitive impairment seen with alcohol use is heterogeneous. We studied cognitive characteristics associated with alcohol use in a “real-world” memory clinic cohort of patients with neurocognitive disorders.

Methods: We used the Toronto Dementia Research Alliance memory clinic research database to generate an age, sex, and education matched sample of individuals with alcohol-related cognitive impairment (ARCI group; n=51) and twice as many individuals without such history (Comparator group; n=102). We compared cognitive domain and subdomain Toronto Cognitive Assessment scores between the two groups using linear regression.while controlling for age, sex, education, concurrent psychiatric disorders, global cognition, and traumatic brain injury.

Results: Mean (SD) age was 67.67 (13.01) years for the ARCI group and 67.96 (12.82) years for the Comparator group. The ARCI and Comparator groups had 35% and 36% females, respectively. Neither global cognition nor other cognitive domains differed significantly between the two groups. Among cognitive subdomains, only the intrusion rates on the delayed recall task were higher (worse performance) in the ARCI group (mean [SD]=0.79 [1.21]) relative to the Comparator group (mean [SD]=0.34 [0.69]; Pcorrected =.018).

Conclusions: Our study suggests that ARCI results in specific deficits involving cognitive control during delayed recall task. This may help advance development of markers to delineate ARCI from other causes of cognitive impairment. Future work may test these findings in larger, well-characterized samples.

J Clin Psychiatry 2025;86(3):24m15738

Author affiliations are listed at the end of this article.

Members Only Content

This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you’re already a subscriber, please log in below to continue reading.

Subscribe Now

Already a member? Log in

  1. Lehmann SW, Fingerhood M. Substance-use disorders in later life. N Engl J Med. 2018;379(24):2351–2360. PubMed CrossRef
  2. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. Lancet. 2024;404(10452):572–628. PubMed CrossRef
  3. Zahr N. Alcohol use disorder and dementia: a review. Alcohol Res. 2024;44(1):03. PubMed CrossRef
  4. Rehm J, Hasan OSM, Black SE, et al. Alcohol use and dementia: a systematic scoping review. Alzheimers Res Ther. 2019;11(1):1. PubMed CrossRef
  5. Sullivan EV, Zahr NM, Sassoon SA, et al. The role of aging, drug dependence, and hepatitis C comorbidity in alcoholism cortical compromise. JAMA Psychiatry. 2018;75(5):474–483. PubMed CrossRef
  6. Daviet R, Aydogan G, Jagannathan K, et al. Associations between alcohol consumption and gray and white matter volumes in the UK biobank. Nat Commun. 2022;13(1):1175. PubMed CrossRef
  7. White AM, Orosz A, Powell PA, et al. Alcohol and aging—an area of increasing concern. Alcohol. 2023;107:19–27. PubMed CrossRef
  8. Kopelman MD, Thomson AD, Guerrini I, et al. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol. 2009;44(2):148–154. PubMed CrossRef
  9. Sullivan EV, Pfefferbaum A. Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: a review. Neuropsychology. 2019;33(6):760–780. PubMed CrossRef
  10. Chandrashekar DV, Steinberg RA, Han D, et al. Alcohol as a modifiable risk factor for Alzheimer’s disease-evidence from experimental studies. Int J Mol Sci. 2023;24(11):9492. PubMed CrossRef
  11. Jones L, Owens L, Thompson A, et al. Informing the development of diagnostic criteria for differential diagnosis of alcohol-related cognitive impairment (ARCI) among heavy drinkers: a systematic scoping review. PLoS One. 2023;18(2):e0280749. PubMed CrossRef
  12. Palm A, Vataja R, Talaslahti T, et al. Incidence and mortality of alcohol-related dementia and Wernicke-Korsakoff syndrome: a nationwide register study. Int J Geriatr Psychiatry. 2022;37(8):10.1002/gps.5775. PubMed CrossRef
  13. Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol. 2013;18(2):203–213. PubMed CrossRef
  14. Stephan RA, Alhassoon OM, Allen KE, et al. Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder. Am J Drug Alcohol Abuse. 2017;43(1):24–43. PubMed CrossRef
  15. Crowe SF, Cammisuli DM, Stranks EK. Widespread cognitive deficits in alcoholism persistent following prolonged abstinence: an updated meta-analysis of studies that used standardised neuropsychological assessment tools. Arch Clin Neuropsychol. 2019;35(1):31–45. PubMed CrossRef
  16. Tang-Wai DF, Strother SC, Pugh B, et al. Toronto Dementia Research Alliance (TDRA) dementia clinical-research platform: an example of research embedded into clinical care. Alzheimers Dement. 2020;16(S11):e041756.
  17. Freedman M, Leach L, Carmela Tartaglia M, et al. The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment. Alzheimers Res Ther. 2018;10(1):65. PubMed CrossRef
  18. Ho DE, Imai K, King G, et al. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1–28. CrossRef
  19. Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172(9):1092–1097. PubMed CrossRef
  20. Welsh K, Butters N, Hughes J, et al. Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol. 1991;48(3):278–281. PubMed CrossRef
  21. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2021. CrossRef
  22. Zhao QY, Luo JC, Su Y, et al. Propensity score matching with R: conventional methods and new features. Ann Transl Med. 2021;9(9):812–812. PubMed CrossRef
  23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995;57(1):289–300. CrossRef
  24. Rensen YCM, Oosterman JM, van Damme JE, et al. Assessment of confabulation in patients with alcohol-related cognitive disorders: the Nijmegen–Venray Confabulation List (NVCL-20). Clin Neuropsychol. 2015;29(6):804–823. PubMed CrossRef
  25. Arts NJ, Walvoort SJ, Kessels RP. Korsakoff’s syndrome: a critical review. Neuropsychiatr Dis Treat. 2017;13:2875–2890. PubMed CrossRef
  26. Kopelman MD. What does a comparison of the alcoholic Korsakoff syndrome and thalamic infarction tell us about thalamic amnesia? Neurosci Biobehav Rev. 2015;54:46–56. PubMed CrossRef
  27. Caetano T, Pinho MS, Ramadas E, et al. Substance abuse and susceptibility to false memory formation: a systematic review and meta-analysis. Front Psychol. 2023;14:1176564. PubMed CrossRef
  28. Gilboa A, Moscovitch M. Ventromedial prefrontal cortex generates pre-stimulus theta coherence desynchronization: a schema instantiation hypothesis. Cortex. 2017;87:16–30. PubMed CrossRef
  29. Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacology. 2022;47(1):72–89. PubMed CrossRef
  30. Guarino A, Favieri F, Boncompagni I, et al. Executive functions in Alzheimer disease: a systematic review. Front Aging Neurosci. 2018;10:437. PubMed CrossRef
  31. McGuinness B, Barrett SL, Craig D, et al. Executive functioning in Alzheimer’s disease and vascular dementia. Int J Geriatr Psychiatry. 2010;25(6):562–568. PubMed CrossRef
  32. Paradis C, Butt P, Shield K, et al. Canada’s Guidance on Alcohol And Health: Final Report. 2023. Accessed May 27, 2024. https://www.ccsa.ca/canadas-guidance- alcohol-and-health-final-report
  33. National Health and Medical Research Council. New Alcohol Guidelines Australia - Alcohol and Drug Foundation. 2023. Accessed May 27, 2024. https://adf.org.au/ reducing-risk/alcohol/alcohol-guidelines/
  34. Paula TCS, Chagas C, Martins LB, et al. Low-risk drinking guidelines around the world: an overview of the current situation. Addict Disord Their Treat. 2020;19(4):218. CrossRef
  35. Nichols E, Merrick R, Hay SI, et al. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community- based autopsy studies of dementia. Lancet Healthy Longev. 2023;4(3):e115–e125. PubMed CrossRef